Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Precision Biosciences (DTIL) FCF Margin (2018 - 2025)

Precision Biosciences (DTIL) has disclosed FCF Margin for 8 consecutive years, with 117461.54% as the latest value for Q3 2025.

  • On a quarterly basis, FCF Margin fell 11642838.0% to 117461.54% in Q3 2025 year-over-year; TTM through Sep 2025 was 10521.35%, a 1045701.0% decrease, with the full-year FY2024 number at 85.44%, up 9120.0% from a year prior.
  • FCF Margin was 117461.54% for Q3 2025 at Precision Biosciences, down from 112627.78% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 409.49% in Q1 2021 to a low of 117461.54% in Q3 2025.
  • A 5-year average of 15916.57% and a median of 212.07% in 2022 define the central range for FCF Margin.
  • Peak YoY movement for FCF Margin: skyrocketed 251099bps in 2021, then crashed -11642838bps in 2025.
  • Precision Biosciences' FCF Margin stood at 397.32% in 2021, then surged by 47bps to 212.07% in 2022, then soared by 44bps to 119.31% in 2023, then plummeted by -2367bps to 2943.57% in 2024, then tumbled by -3890bps to 117461.54% in 2025.
  • Per Business Quant, the three most recent readings for DTIL's FCF Margin are 117461.54% (Q3 2025), 112627.78% (Q2 2025), and 65917.24% (Q1 2025).